Fragment-Based Drug Discovery: Difference between revisions
No edit summary |
No edit summary |
||
Line 15: | Line 15: | ||
Click on each amino acid to view the hydrophobic interactions with the ligand: | Click on each amino acid to view the hydrophobic interactions with the ligand: | ||
{ | {| border="1" cellpadding="2" | ||
|- | |||
| width="150pt" align="center" | <scene name='Sandbox_reserved_394/Tyrosine_199/3'>Tyr199</scene> | |||
| width="150pt" align="center" | <scene name='Sandbox_reserved_394/Valine_145/1'>Val145</scene> | |||
| width="150pt" align="center" | <scene name='Sandbox_reserved_394/Leucine_134/1'>Leu134</scene> | |||
| width="150pt" align="center" | <scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Phe109</scene> | |||
|- | |||
| align="center" | <scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene> || align="center" | <scene name='Sandbox_reserved_394/Tyrosine_105/1'>Tyr105</scene> || align="center" | <scene name='Sandbox_reserved_394/Phe_101/1'>Phe101</scene> || align="center" | <scene name='Sandbox_reserved_394/Glycine_142/1'>Gly142</scene> | |||
|} | |||
</StructureSection> | </StructureSection> |